- Home
- CICB vs FBIOP Comparison
CICB vs FBIOP Comparison
Compare CICB & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CICB
- FBIOP
- Stock Information
- Founded
- CICB N/A
- FBIOP N/A
- Country
- CICB United States
- FBIOP United States
- Employees
- CICB N/A
- FBIOP 101
- Industry
- CICB Finance/Investors Services
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- CICB Finance
- FBIOP Health Care
- Exchange
- CICB Nasdaq
- FBIOP Nasdaq
- Market Cap
- CICB N/A
- FBIOP N/A
- IPO Year
- CICB 2024
- FBIOP N/A
- Fundamental
- Price
- CICB $25.42
- FBIOP $6.54
- Analyst Decision
- CICB
- FBIOP
- Analyst Count
- CICB 0
- FBIOP 0
- Target Price
- CICB N/A
- FBIOP N/A
- AVG Volume (30 Days)
- CICB N/A
- FBIOP N/A
- Earning Date
- CICB N/A
- FBIOP N/A
- Dividend Yield
- CICB N/A
- FBIOP N/A
- EPS Growth
- CICB N/A
- FBIOP N/A
- EPS
- CICB N/A
- FBIOP N/A
- Revenue
- CICB N/A
- FBIOP N/A
- Revenue This Year
- CICB N/A
- FBIOP N/A
- Revenue Next Year
- CICB N/A
- FBIOP N/A
- P/E Ratio
- CICB N/A
- FBIOP N/A
- Revenue Growth
- CICB N/A
- FBIOP N/A
- 52 Week Low
- CICB N/A
- FBIOP N/A
- 52 Week High
- CICB N/A
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- CICB 51.92
- FBIOP 40.38
- Support Level
- CICB $25.22
- FBIOP $6.27
- Resistance Level
- CICB $25.74
- FBIOP $7.09
- Average True Range (ATR)
- CICB 0.18
- FBIOP 0.30
- MACD
- CICB 0.01
- FBIOP 0.04
- Stochastic Oscillator
- CICB 51.90
- FBIOP 36.59
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.